InvestSMART

Recce Pharmaceuticals Ltd (ASX:RCE)

ALERT: Price-sensitive ASX Announcement for RCE
Current share price for RCE : $0.363 -0.098 (-21.20%)+
Announcement
Release
26 Jun 2026 10:03AM
Price at Release
$0.460
Full Release
download
Summary
Recce Pharmaceuticals Ltd has announced a capital raising initiative through an institutional Placement and a Share Purchase Plan (SPP) to raise a total of AUD 8 million. The Placement aims to raise AUD 4 million by issuing 10 million new shares at AUD 0.40 per share, a discount to recent trading prices. The SPP allows existing shareholders to purchase up to AUD 30,000 in new shares, potentially raising an additional AUD 4 million. Participants in both the Placement and SPP are offered free attaching options and piggyback options, subject to meeting regulatory approvals. The funds are intended to strengthen the company's balance sheet, support clinical trials, and facilitate a commercial agreement with a Middle Eastern pharmaceutical company. This fundraising aligns with Recce's ongoing efforts to develop its anti-infective pipeline, including products targeting antibiotic-resistant superbugs.
Key Points
  • Recce Pharmaceuticals Ltd raising AUD 8 million through Placement and SPP.
  • Placement shares priced at AUD 0.40, a discount to market price.
  • SPP allows shareholders to purchase up to AUD 30,000 in new shares.
  • Funds to support balance sheet, clinical trials, and commercial licensing.
  • Offer includes attaching options and piggyback options for participants.
  • Regulatory approvals pending for options structure and terms.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.